Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and/or metformin on hepatocellular carcinoma cells: in vitro study

Survivin in survival of hepatocellular carcinoma

(2016) Changqing Su   CANCER LETTERS

Tea polyphenols epigallocatechin gallete and theaflavin restrict mouse liver carcinogenesis through modulation of self-renewal Wnt and hedgehog pathways

(2016) Subhayan Sur et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity

(2016) Sainan Li et al.   Scientific Reports

Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145

(2015) Hongzhi Lu et al.   TUMOR BIOLOGY

Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma

(2014) Sheng-Xian Yuan et al.   CANCER LETTERS

Metformin Inhibits Angiogenesis Induced by Interaction of Hepatocellular Carcinoma with Hepatic Stellate Cells

(2014) Hongmei Qu et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review

(2014) Yukio Osaki et al.   HEPATOLOGY RESEARCH

Metformin Inhibits Hepatocellular Carcinoma in a Cirrhosis Model

(2014) D.K. DePeralta et al.   JOURNAL OF SURGICAL RESEARCH

EGCG Enhances the Efficacy of Cisplatin by Downregulating hsa-miR-98-5p in NSCLC A549 Cells

(2014) Dong-Hu Zhou et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV

(2014) Jiongjiong Lu et al.   TUMOR BIOLOGY

Tea polyphenols induced apoptosis of breast cancer cells by suppressing the expression of Survivin

(2014) Xuesong Chen et al.   Scientific Reports

Metformin Inhibits Growth of Hepatocellular Carcinoma Cells by Inducing Apoptosis Via Mitochondrion-mediated Pathway

(2013) Yu Xiong et al.   Asian Pacific Journal of Cancer Prevention

Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma

(2013) Jorge Filmus et al.   FEBS Journal

Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma

(2013) Wenling Zhang et al.   JOURNAL OF MOLECULAR HISTOLOGY

Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo

(2013) XIANBIN CAI et al.   ONCOLOGY REPORTS

Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: A clinical and in vitro investigation

(2013) YAN ZHAO et al.   ONCOLOGY REPORTS

In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma

(2012) Zhan Qu et al.   HEPATOLOGY RESEARCH

Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate

(2012) Xiaobo Zhang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Cancer prevention by targeting angiogenesis

(2012) Adriana Albini et al.   Nature Reviews Clinical Oncology

Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer Cells

(2011) Y. Zhuang et al.   MOLECULAR CANCER RESEARCH

Recent Advances in Anti-Survivin Treatments for Cancer

(2010) R. Kanwar et al.   CURRENT MEDICINAL CHEMISTRY

Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro

(2010) Mingqian Feng et al.   INTERNATIONAL JOURNAL OF CANCER

Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma

(2009) Hirofumi Shirakawa et al.   CANCER SCIENCE

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis

(2009) Yohei Shirakami et al.   CANCER SCIENCE